http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-318884-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b6fc801b5bfe5304ffa40d938db6e09
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-84
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-70
filingDate 1963-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf657d1f5cb83b412055e1b88563564b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dc45f8b711de4f1c4a3b6c9b4954791
publicationDate 1969-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-318884-B
abstract The invention comprises imidazoles of the general formula <FORM:1026409/C2/1> and the non-toxic salts with inorganic or organic acids, wherein R is -OH or -SH; R1 is H, methyl, carboxy or carbalboxy; R2 is C1- 10-alkyl, C2- 6-alkenyl, C3- 7-cycloalkyl, o , o -dialkoxyalkyl (at most 6C), dialkylamino alkyl (in all at most 10C and wherein the two alkyl groups together with N can form a 5-7 membered ring), phenyl, phenylalkyl (at most 4C in the alkylene residue) the phenyl group being optionally substituted by halogen, OH, CN, NO2, CF3, CO2H, CH3CO2, CO2C2H5, alkylthio, alkanoyl (at most 4C) or 1-3 alkyl or alkoxy groups (at most 4C in each radical) and the preparation thereof (wherein R is OH) by reacting HCHO, and amine R2NH2 and a ketone <FORM:1026409/C2/2> wherein R11 is methyl or carbalkoxy in a polar solvent, or first forming the Schiffs base and reacting this with III; or (wherein R is SH) by reacting HCHO, R2NH2 and III in a polar solvent, with a reactant which gives off the hydrosulphide ion; or (wherein R is OA and R1 is H) by reacting an isocyanate R2NCO with an alkanol <FORM:1026409/C2/3> and oxidizing the reaction product, e.g. Opponauer reaction. 1 -(N-phenyl-N1-ureido)-propanol-(2) is prepared from 2-hydroxypropylamine and PhNCO. Pharmaceutical compositions comprise compounds I (or their salts) and a pharmaceutically acceptable carrier therefor. The compositions, which possess analgetic, central nervous system depressant, antipyretic and anti-inflammatory activity may be formulated as tablets, dragees, suppositories or solutions for injection.
priorityDate 1962-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365

Total number of triples: 27.